Find treatment options for idiopathic pulmonary fibrosis as well as steps you can take to protect your lungs and slow the disease.
Those who suffer from idiopathic pulmonary fibrosis (IPF) may be breathing a little easier. In October 2014, the Food and Drug Administration approved two new drugs for IPF — the first ever produced that can treat this disease. IPF is a scarring or thickening of the lungs that has no known cause. As the scarring … Read More
Scleroderma is a rare disease of the autoimmune system that many people haven’t heard of. Yet recognizing the symptoms can help you get treatment faster – and provide the best chance for a successful outcome. The disease is characterized by hard skin — “sclero” means “thickening” and “derma” means “skin.” It is a disease in which dense, thick fibrous … Read More
Register for Online Chat Do you have a question about interstitial lung disease? Daniel Culver, MD, Staff Physician, and Joseph Parambil, MD, Associate Staff, both of the Department of Pulmonary, Allergy and Critical Care Medicine, will answer your questions about this topic during a live webchat Wednesday, Nov. 7, 2012, at noon (ET). Interstitial Lung … Read More
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Register for Online Chat Do you have a question about pulmonary hypertension? Gustavo Heresi-Davila, MD, Department of Pulmonary, Allergy and Critical Care Medicine, and Nicholas G. Smedira, MD, Department of Thoracic and Cardiovascular Surgery, will answer your questions about this topic during a live webchat Wednesday, Sept. 26, 2012, at noon (ET). Pulmonary Hypertension Live … Read More